Stay updated on SHR6390 & Pyrotinib in HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the SHR6390 & Pyrotinib in HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SHR6390 & Pyrotinib in HER2+ Breast Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The page revision label now reads v3.5.4, replacing the previous v3.5.3; this indicates a minor metadata update without altering the study content or data.
    Difference
    0.2%
    Check dated 2026-05-15T15:23:53.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    The page’s displayed software/version label changes from Revision v3.5.2 to v3.5.3, reflecting a site update rather than any modification to the clinical trial’s study information.
    Difference
    0.1%
    Check dated 2026-04-24T06:40:41.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    New revision entry v3.5.2 added to the history, replacing the previous v3.5.0 entry.
    Difference
    0.1%
    Check dated 2026-04-17T02:48:06.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    A new revision entry v3.5.0 was added to the record history. The previous revision v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-19T05:16:46.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added to the history. Revision: v3.4.2 was removed from the history.
    Difference
    0.1%
    Check dated 2026-03-12T03:02:51.000Z thumbnail image
  9. Check
    113 days ago
    Change Detected
    Summary
    Added a new revision label (v3.4.2) to the record history and removed older notices (v3.4.1 and the funding-status notice). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.9%
    Check dated 2026-02-11T11:44:17.000Z thumbnail image

Stay in the know with updates to SHR6390 & Pyrotinib in HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SHR6390 & Pyrotinib in HER2+ Breast Cancer Clinical Trial page.